Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sofosbuvir (sovaldi) (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
phyllanthus (1 trial)
Fatty Liver (Phase 2)
Hepatitis C (Phase 3)
Liver Diseases (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Trials (3 total)
Trial APIs (3 total)